Zai Lab Limited (NASDAQ:ZLAB) reported Q2 EPS of ($1.44), $0.37 worse than the analyst estimate of ($1.07). Revenue for the quarter came in at $47.6 million versus the consensus estimate of $48.88 million.
Zai Lab Limited (NASDAQ:ZLAB) reported Q2 EPS of ($1.44), $0.37 worse than the analyst estimate of ($1.07). Revenue for the quarter came in at $47.6 million versus the consensus estimate of $48.88 million.